#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
proLékaře.cz

Athero Review - Issue 2/2023

Guidelines

66
Statement CSAT on Consensus statement of the European Atherosclerosis Society: Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis

Michal Vrablík, Vladimír Bláha, Renata Cífková, Tomáš Freiberger, David Karásek, Pavel Kraml, Jan Piťha, Hana Rosolová, Vladimír Soška, Tomáš Štulc, Lukáš Zlatohlávek Za Výbor Čsat, Jana Mašková

Reviews

77
The importance of nonstatin therapies for LDL-cholesterol lowering in the management of very high and high atherosclerotic cardiovascular risk

Daniel Pella

85
Bempedoic acid in the context of current hypolipidemic treatment options and the results of the CLEAR OUTCOMES trial

Eva Tůmová, Michal Vrablík

95
Genetic testing – polygenic score

Jaroslav A. Hubáček

103
Parallel intervention of arterial hypertension and dyslipidemia – from risk identification to successful prevention

Eva Tůmová, Michal Vrablík

109
Hyperlipidemic crisis as a risk factor for acute pancreatitis

Martin Bajer, Jo O Fortunato, Jan Maňák, Vladimír Bláha

112
An unconventional manifestation of severe hypercholesterolemia – sudden senzorineural hearing loss? Case report

Miriam Kozárová, Zuzana Kozelová

Announcements

117
Inclisiran receives reimbursement and enters clinical practice

Kristýna Čillíková

121
Comments to recent literature of interest

Eva Tůmová

Personal News

123
Dvojnásob 25letý Michal Vrablík
125
Kulatý Vladimír Soška (nikoli však postavou)

Athero Review

Issue 2
2023 Issue 2
Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#